Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression.
Kiyofumi ShimojiTaku NakashimaTakeshi MasudaMasashi NambaShinjiro SakamotoKakuhiro YamaguchiYasushi HorimasuTakahiro MimaeShintaro MiyamotoHiroshi IwamotoKazunori FujitakaHironobu HamadaMorihito OkadaNoboru HattoriPublished in: Journal of translational medicine (2023)
The hypoxia-inducible factor 1 pathway is critical in lung cancer with interstitial pneumonia and could be a therapeutic target for mitigating interstitial pneumonia-mediated lung cancer progression.